Human coagulation factor IX
Each vial with lyophilized powder contains the following active pharmaceutical ingredient:
Octanine F 250: 250 IU of Human coagulation factor IX.
Octanine F 500: 500 IU of Human coagulation factor IX.
Treatment and prophylaxis of bleeding in patients with haemophilia B (congenital factor IX deficiency) or acquired deficiency of Factor IX.
- Hypersensitivity to the active pharmaceutical ingredient or to any other component of the product.
- Heparin induced thrombocytopenia (HIT type II).
Octanine F 250: box containing one vial with lyophilized powder + one vial with 5 mL of solvent + the injection kit.
Octanine F 500: box containing one vial with lyophilized powder + one vial with 10 mL of solvent + the injection kit.